An AI startup supported by conglomerate SK Group has introduced what could be the first pharmacy-specific platform powered by generative AI in South Korea. Intended for use by professionals in the pharmaceutical industry, including researchers and…
Continue Reading
What You Should Know:
– Dexcom, the global leader in continuous glucose monitoring (CGM), has achieved another groundbreaking milestone by launching the first generative AI (GenAI) platform in glucose biosensing technology, Stelo.
– The Stelo platform…
Continue Reading
What You Should Know:
– Deaconess Health System, a nationally recognized leader in healthcare innovation and patient-centered care, is expanding the use of Abridge, a generative AI platform for clinical documentation, across its 19-hospital network.
– Following an overwhelmingly…
Continue Reading
What You Should Know:
– SpinSci, a healthcare technology company specializing in AI-powered patient engagement solutions secures $53M majority investment from Aldrich Capital Partners.
– The company plans to use the funding to accelerate SpinSci’s growth…
Continue Reading
What You Should Know:
– Promising results from a pilot program using a generative AI platform to help with clinical documentation show improvements in both patient and clinician experiences at the University of Chicago Medicine, according…
Continue Reading
What You Should Know:
– Greenway Health, a provider of health information technology services, has joined the Amazon Web Services (AWS) Partner Network (APN).
– The strategic collaboration will enable Greenway to leverage AWS’s cloud infrastructure…
Continue Reading
What You Should Know:
– Xsolis, a provider of AI-driven solutions for healthcare administration, has announced the launch of a new generative AI platform designed to streamline the appeals process for healthcare providers.
– MultiCare Health…
Continue Reading
Researchers from the National Institutes of Health are using large language models to develop an artificial intelligence framework to streamline the clinical trial matching process and more quickly link potential volunteers to relevant trials…
Continue Reading
Converge Bio has raised $5.5 million in seed funding led by TLV Partners.WHAT IT DOES
Converge Bio is a generative AI hub for Biotech and Pharma that allows the accelerated discovery and development of drugs…
What You Should Know:
– Converge Bio, a generative AI platform for accelerated drug discovery and development, today announced it has raised $5.5 million in seed funding, led by TLV Partners.
– Converge Bio’s platform uses large language…
Continue Reading
